Polymorphisms in abcb1 associated with a lack of clinical response to medicaments

作者: Manfred Uhr , Bertram Müller-Myhsok , Florian Holsboer

DOI:

关键词:

摘要: The present invention relates to methods, compositions, kits and reagents for determining the prognosis of a clinical response in human patient medicament which acts central nervous system (CNS) is substrate ABCB1 protein. Further, combination medicaments treatment patients having specific polymorphisms gene.

参考文章(61)
Manfred Ackenheil, Klaus Weber, Differing response to antipsychotic therapy in schizophrenia: pharmacogenomic aspects Dialogues in clinical neuroscience. ,vol. 6, pp. 71- 77 ,(2004)
Alan F Schatzberg, Charles B Nemeroff, None, The American Psychiatric Publishing Textbook of Psychopharmacology ,(2009)
F. Thiebaut, T. Tsuruo, H. Hamada, M. M. Gottesman, I. Pastan, M. C. Willingham, Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues Proceedings of the National Academy of Sciences of the United States of America. ,vol. 84, pp. 7735- 7738 ,(1987) , 10.1073/PNAS.84.21.7735
James G. Booth, P. H. Westfall, S. S. Young, Resampling-Based Multiple Testing. Journal of the American Statistical Association. ,vol. 89, pp. 354- ,(1994) , 10.2307/2291234
Soichiro Ito, Ichiro Ieiri, Mizuho Tanabe, Akito Suzuki, Shun Higuchi, Kenji Otsubo, Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects. Pharmacogenetics. ,vol. 11, pp. 175- 184 ,(2001) , 10.1097/00008571-200103000-00008